For the prevention of breast cancer, risk-reducing bilateral mastectomy is an effective procedure to reduce breast cancer incidence for both BRCA1 and BRCA2 PV carriers and breast cancer mortality for BRCA1 PV carriers [7,8]. This evidence concerns the gene BRCA2 and breast cancer.